{"schema":"hottub-news/story/v1","story":"st_nytts5m3qu26nq6byf7q","title":"Roche fait l'étal de son taux de succès en phase III","title_en":"Roche showcases its success rate in phase III","outlets":1,"brief":null,"page":"https://hottub.news/stories/roche-showcases-its-success-rate-in-phase-iii-nytts5m3qu","count":1,"items":[{"id":"n_nytts5m3qu26nq6byf7q","seq":402577,"kind":"article","title":"Roche fait l'étal de son taux de succès en phase III","title_en":"Roche showcases its success rate in phase III","url":"https://www.bluewin.ch/fr/infos/economie/roche-fait-l-tal-de-son-taux-de-succ-s-en-phase-iii-li.3616362","summary":"Le géant des médicaments et du diagnostic Roche revendique en 2026 un taux de succès de 80% pour ses programmes cliniques avancés, contre 65% en 2025, à l'occasion de sa journée pour investisseurs lundi.","published":"2026-09-28T09:54:11Z","seen":"2026-09-28T10:46:55Z","lang":"fr","country":"CH","source":{"id":"kite-bluewin-ch-5267ac","name":"bluewin.ch","domain":"bluewin.ch","outlet":{"wikidata":"Q886096","name":"Q886096","type":"other","designations":["business"]}},"via":"kite-bluewin-ch-5267ac","entities":[{"id":"Q2160232","name":"Roche","type":"org"}],"story":"st_nytts5m3qu26nq6byf7q","category":"economy-business","category_p":0.6600000262260437,"sentiment":"positive","tone":0.6399999856948853,"political":0.05000000074505806}]}